En Es
Categorías

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological functions. The company also provides sequencing and array-based solutions for genetic analysis, as well as genotyping, NIPT and whole-genome sequencing services for government laboratories, hospitals, an ...
Productos Resumen
Close

Sobre Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological functions. The company also provides sequencing and array-based solutions for genetic analysis, as well as genotyping, NIPT and whole-genome sequencing services for government laboratories, hospitals, and reference laboratories, among others.
Facebook Twitter Google+ Linked in
NGS Test

NGS Test

Modelo: MiSeqDx Cystic Fibrosis 139-Variant Assay
Solicite información

Descripción:

The MiSeqDx Cystic Fibrosis 139-Variant Assay is an FDA-cleared in vitro diagnostic (IVD) next-generation sequencing test designed to detect 139 CFTR variants. It provides a fully integrated molecular CF testing solution on the MiSeqDx instrument and includes all index primers and reagents needed for library preparation, sample multiplexing, and sequencing in a single kit.


Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
Illumina (NGS Test)
* Mensaje

Derecho de autor © 2000-2020 TradeMed.com. Todos los derechos reservados. | Términos y condiciones